Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Ostet Ginecol Med Perinat ; 111(6): 379-87, 1990.
Artigo em Italiano | MEDLINE | ID: mdl-2102065

RESUMO

Thirty patients in fertile age affected by ectropion were treated with Polydeoxyribonucleotide (PDRN) (*) vaginal suppositories for 24 days. No other local or general therapy was allowed. The following parameters were evaluated: local symptomatology, tolerability and compliance, vaginal cytology, colposcopic examination, bioptic sampling of affected area prior to and after treatment, and local immune response. The results show the efficacy of PDRN. In fact, after the treatment: reduction of subjective symptomatology with decrease of average score for each symptom; excellent or good tolerability and acceptability; reduced inflammation; increased iodine-dark areas; reestablishment of normal balance in T- and B-lymphocytic populations have been found.


Assuntos
Polidesoxirribonucleotídeos/uso terapêutico , Doenças do Colo do Útero/tratamento farmacológico , Adolescente , Adulto , Colo do Útero/citologia , Colo do Útero/patologia , Colposcopia , Tolerância a Medicamentos , Feminino , Humanos , Pessoa de Meia-Idade , Polidesoxirribonucleotídeos/administração & dosagem , Supositórios , Doenças do Colo do Útero/diagnóstico , Doenças do Colo do Útero/patologia , Esfregaço Vaginal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...